EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 32 / No 8-9 (Août–Septembre 2016) Med Sci (Paris), 32 8-9 (2016) 725-731 References
Free Access
Issue
Med Sci (Paris)
Volume 32, Number 8-9, Août–Septembre 2016
Page(s) 725 - 731
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20163208020
Published online 12 September 2016
  1. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006 ; 6 : 449–458. [CrossRef] [PubMed] [Google Scholar]
  2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009 ; 139 : 871–890. [CrossRef] [PubMed] [Google Scholar]
  3. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013 ; 13 : 97–110. [CrossRef] [PubMed] [Google Scholar]
  4. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998 ; 153 : 865–873. [CrossRef] [PubMed] [Google Scholar]
  5. Morel AP, Hinkal GW, Thomas C, et al. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 2012 ; 8 : e1002723. [CrossRef] [PubMed] [Google Scholar]
  6. Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 2014 ; 16 : 488–494. [CrossRef] [PubMed] [Google Scholar]
  7. Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: plastic surgeons of breast cancer. World J Clin Oncol 2014 ; 5 : 311–322. [CrossRef] [PubMed] [Google Scholar]
  8. Richards EJ, Zhang G, Li ZP, Permuth-Wey J, et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF): LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem 2015 ; 290 : 6857–6867. [CrossRef] [PubMed] [Google Scholar]
  9. Fischer KR, Durrans A, Lee S, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015 ; 527 : 472–476. [CrossRef] [PubMed] [Google Scholar]
  10. Zheng X, Carstens JL, Kim J, et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015 ; 527 : 525–530. [CrossRef] [PubMed] [Google Scholar]
  11. Spaderna S, Schmalhofer O, Hlubek F, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006 ; 131 : 830–840. [CrossRef] [PubMed] [Google Scholar]
  12. Pasquier J, Abu-Kaoud N. Al Thani H, Rafii A. Epithelial to mesenchymal transition in a clinical perspective. J Oncol 2015 ; 2015 : 792182. [CrossRef] [PubMed] [Google Scholar]
  13. Eckert MA, Lwin TM, Chang AT, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011 ; 19 : 372–386. [CrossRef] [PubMed] [Google Scholar]
  14. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 2004 ; 6 : 625–630. [CrossRef] [PubMed] [Google Scholar]
  15. Ansieau S, Bastid J, Doreau A, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008 ; 14 : 79–89. [CrossRef] [PubMed] [Google Scholar]
  16. Morel AP, Lièvre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008 ; 3 : e2888. [CrossRef] [PubMed] [Google Scholar]
  17. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 ; 133 : 704–715. [CrossRef] [PubMed] [Google Scholar]
  18. Jolly MK, Boareto M, Huang B, et al. Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol 2015 ; 5 : 155. [CrossRef] [PubMed] [Google Scholar]
  19. Ocaña OH, Córcoles R, Fabra A, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012 ; 22 : 709–724. [CrossRef] [PubMed] [Google Scholar]
  20. Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013 ; 339 : 580–584. [CrossRef] [PubMed] [Google Scholar]
  21. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004 ; 4 : 839–849. [CrossRef] [PubMed] [Google Scholar]
  22. Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996 ; 76 : 69–125. [PubMed] [Google Scholar]
  23. Scholer-Dahirel A, Costa A, Mechta-Grigoriou F. Control of cancer-associated fibroblasts function by oxidative stress: a new piece in the puzzle. Cell Cycle 2013 ; 12 : 2169. [CrossRef] [PubMed] [Google Scholar]
  24. Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 1990 ; 87 : 7235–7239. [CrossRef] [Google Scholar]
  25. Lanigan F, O’Connor D, Martin F, Gallagher WM. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci 2007 ; 64 : 3159–3184. [CrossRef] [PubMed] [Google Scholar]
  26. Duffy MJ. Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem 2002 ; 48 : 1194–1197. [PubMed] [Google Scholar]
  27. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
  28. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005 ; 23 : 344–346. [CrossRef] [PubMed] [Google Scholar]
  29. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996, 32A : 2534–2539. [CrossRef] [PubMed] [Google Scholar]
  30. Tichet M, Prod’Homme V, Fenouille N, et al. Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nat Commun 2015 ; 6 : 6993. [CrossRef] [PubMed] [Google Scholar]
  31. Suchorska WM, Lach MS. The role of exosomes in tumor progression and metastasis. Oncol Rep 2016 ; 35 : 1237–1244. [CrossRef] [PubMed] [Google Scholar]
  32. Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015 ; 527 : 329–335. [CrossRef] [PubMed] [Google Scholar]
  33. Nowell PC. The clonal evolution of tumor cell populations. Science 1976 ; 194 : 23–28. [CrossRef] [PubMed] [Google Scholar]
  34. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997 ; 3 : 730–737. [CrossRef] [PubMed] [Google Scholar]
  35. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007 ; 449 : 473–477. [CrossRef] [PubMed] [Google Scholar]
  36. Wagenblast E, Soto M, Gutiérrez-Ángel S, et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature 2015 ; 520 : 358–362. [CrossRef] [PubMed] [Google Scholar]
  37. Bethge A, Schumacher U, Wedemann G. Simulation of metastatic progression using a computer model including chemotherapy and radiation therapy. J Biomed Inform 2015 ; 57 : 74–87. [CrossRef] [PubMed] [Google Scholar]
  38. Maley CC, Galipeau PC, Finley JC, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 2006 ; 38 : 468–473. [CrossRef] [PubMed] [Google Scholar]
  39. Treps L, Gavard J. L’angiogenèse tumorale. Med Sci (Paris) 2015 ; 31 : 989–995. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Hubert S, Abastado JP. Les étapes précoces du processus métastatique. Med Sci (Paris) 2014 ; 30 : 378–384. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  41. Albagli O. Protéger et sévir : p53, métabolisme et suppression tumorale. Med Sci (Paris) 2015 ; 31 : 869–880. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  42. Teillaud JL. Microenvironnements tumoraux : conflictuels et complémentaires. Med Sci (Paris) 2014 ; 30 : 343–462. [Google Scholar]
  43. Puisieux A, Ansieau S. La dissémination précoce de cellules métastatiques. Med Sci (Paris) 2009 ; 25 : 28–29. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.